|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,420.15 INR | +0.53% |
|
+2.70% | +14.59% |
| 06-26 | Lupin Limited Receives Tentative Approval From U.S. Food And Drug Administration For Enzalutamide Tablets | CI |
| 06-26 | Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets | MT |
| Market Cap | 1,101B 11.64B 10.19B 9.41B 8.79B 16.54B 16.92B 113B 43.72B 543B 43.72B 42.76B 1,885B | P/E 2026 |
19.9x | P/E 2027 * | 23.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1,087B 11.5B 10.07B 9.3B 8.68B 16.34B 16.72B 112B 43.19B 537B 43.2B 42.25B 1,863B | EV / Sales 2026 |
3.69x | EV / Sales 2027 * | 3.57x |
| Free-Float |
52.97% | Yield 2026 |
0.78% | Yield 2027 * | 0.53% |
Last Transcript: Lupin Limited
| 1 day | +0.53% | ||
| 1 week | +2.70% | ||
| Current month | +6.50% | ||
| 1 month | +7.09% | ||
| 3 months | +4.65% | ||
| 6 months | +16.30% | ||
| Current year | +14.59% |
| 1 week | 2,336.9 |  | 2,439 |
| 1 month | 2,219.8 | | 2,439 |
| Current year | 2,072.95 | | 2,492 |
| 1 year | 1,838.65 | | 2,492 |
| 3 years | 884.9 | | 2,492 |
| 5 years | 583.05 | | 2,492 |
| 10 years | 505 | | 2,492 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2013-08-31 | |
| Director of Finance/CFO | 61 | 2007-08-12 | |
Shahin Fesharaki
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 2008-10-07 | |
| Director/Board Member | 58 | 1996-12-31 | |
| Chairman | 82 | 2017-08-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | +2.70% | +24.89% | +168.10% | 11.64B | |
| +1.81% | +11.60% | +58.61% | +164.79% | 1,097B | |
| +1.51% | +11.77% | +69.61% | +57.53% | 622B | |
| +0.38% | +10.56% | +39.49% | +90.88% | 449B | |
| -0.87% | +6.34% | +29.51% | +24.01% | 334B | |
| +0.43% | +5.74% | +42.00% | +27.44% | 294B | |
| +0.98% | +3.13% | +32.35% | +41.42% | 286B | |
| +1.07% | +3.62% | -27.46% | -41.99% | 213B | |
| +0.62% | +4.59% | +30.10% | +63.03% | 195B | |
| -1.21% | +1.17% | +14.15% | +66.20% | 157B | |
| Average | +0.21% | +6.40% | +31.33% | +66.14% | 365.84B | |
| Weighted average by Cap. | +0.24% | +8.70% | +43.55% | +82.26% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 272B 2.87B 2.52B 2.32B 2.17B 4.08B 4.18B 27.95B 10.79B 134B 10.79B 10.55B 465B | 296B 3.14B 2.75B 2.53B 2.37B 4.46B 4.56B 30.5B 11.78B 146B 11.78B 11.52B 508B |
| Net income | 49.02B 518M 454M 419M 391M 737M 753M 5.04B 1.95B 24.18B 1.95B 1.9B 83.96B | 45.98B 486M 426M 393M 367M 691M 707M 4.73B 1.83B 22.68B 1.83B 1.79B 78.76B |
| Net Debt | -13.22B -140M -122M -113M -106M -199M -203M -1.36B -525M -6.52B -525M -514M -22.65B | -42.53B -450M -394M -364M -340M -639M -654M -4.38B -1.69B -20.98B -1.69B -1.65B -72.85B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-30 | ₹2,420.15 | +0.53% | 36,595 |
| 26-06-29 | ₹2,407.45 | +2.79% | 56,695 |
| 26-06-25 | ₹2,342.15 | -1.08% | 18,125 |
| 26-06-24 | ₹2,367.80 | +0.48% | 17,731 |
| 26-06-23 | ₹2,356.55 | +0.73% | 32,265 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LUPIN Stock
Select your edition
All financial news and data tailored to specific country editions
